---
schema_version: "secwatch.filing_event.v1"
accession: "0001217234-25-000045"
form_type: "8-K"
ticker: "CDNA"
cik: "0001217234"
company_name: "CareDx, Inc."
filed_at: "2025-08-06T23:59:59+00:00"
generated_at: "2026-05-17T18:56:57.737948+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# CareDx Q2 adjusted revenue up 14% YoY to $90.5M; narrows FY guidance; appoints new CFO

## Summary
- Q2 adjusted revenue $90.5M (+14% YoY); GAAP revenue $86.7M (-6% YoY) due to $3.8M aged receivable write-off.
- Testing services volume ~49,500 (+13% YoY); AlloSure Kidney volume up ~20% YoY.
- GAAP net loss $8.6M ($0.16/sh) vs $4.6M loss; non-GAAP net income $5.6M ($0.10/sh) vs $13.6M.
- Adjusted EBITDA $9.1M (excl. $3.8M write-off) vs prior year loss $0.3M.
- CFO change: Nathan Smith appointed, effective Aug 7, 2025; Abhishek Jain retired; Smith receives $400K salary, RSUs, PSUs.

## SEC filing metadata
- accession: 0001217234-25-000045
- form_type: 8-K
- ticker: CDNA
- cik: 0001217234
- company_name: CareDx, Inc.
- filed_at: 2025-08-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01, 5.02, 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1217234/000121723425000045/0001217234-25-000045-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1217234/000121723425000045/cdna-20250806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001217234-25-000045
- JSON: https://secwatch.observer/filing/0001217234-25-000045.json
- Plain text: https://secwatch.observer/filing/0001217234-25-000045.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.